MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 824-834

  Panizo, Sara ^a   Naves Díaz, Manuel ^a   Carrillo López, Natalia ^a   Martínez Arias, Laura ^a   Fernández Martín, José Luis ^a   Ruiz Torres, María Piedad ^b   Cannata Andía, Jorge B ^a,c   Rodríguez, Isabel ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; CALCIUM; CREATININE; MICRORNA; MICRORNA 125; MICRORNA 133B; MICRORNA 135; MICRORNA 141; MICRORNA 200A; MICRORNA 204; MICRORNA 211; MICRORNA 29B; PARATHYROID HORMONE; PHOSPHORUS; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; UREA; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE II-A; CTNNBIP1 PROTEIN, RAT; CULTURE MEDIUM; HDAC4 PROTEIN, RAT; HISTONE DEACETYLASE; MIRN133 MICRORNA, RAT; MIRN211 MICRORNA, RAT; MIRN29 MICRORNA, RAT; PHOSPHATE INTAKE; RUNX2 PROTEIN, RAT; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; GENE EXPRESSION; HYPERPHOSPHATEMIA; INFANT; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; UREA BLOOD LEVEL; UREMIA; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CALCIFICATION; ADMINISTRATION AND DOSAGE; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; GENETICS; METABOLISM; NEPHRECTOMY; PATHOLOGY; PHOSPHATE INTAKE; SMOOTH MUSCLE CELL; WISTAR RAT;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; AORTA; CALCIUM; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CULTURE MEDIA; GENE EXPRESSION; HISTONE DEACETYLASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEPHRECTOMY; PHOSPHORUS; PHOSPHORUS, DIETARY; RATS; RATS, WISTAR; UREMIA; VASCULAR CALCIFICATION;

EID: 84959885518     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014050520     Document Type: Article

References (42)

1. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19: 1827-1835, 2008
2. Rodríguez-García M, Gómez-Alonso C, Naves-Díaz M, Diaz-Lopez JB, Diaz-Corte C, Cannata-Andía JB; Asturias Study Group: Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 24: 239-246, 2009
3. Naik V, Leaf EM, Hu JH, Yang HY, NguyenNB, Giachelli CM, Speer MY: Sources of cells that contribute to atherosclerotic intimal calcification: An in vivo genetic fate mapping study. Cardiovasc Res 94: 545-554, 2012
4. Speer MY, Yang HY, Brabb T, Leaf E, Look A, LinWL, Frutkin A, Dichek D, Giachelli CM: Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 104: 733-741, 2009
5. Xie C, Ritchie RP, Huang H, Zhang J, Chen YE: Smooth muscle cell differentiation in vitro: Models and underlying molecular mechanisms. Arterioscler Thromb Vasc Biol 31: 1485-1494, 2011
6. House SJ, PotierM, Bisaillon J, Singer HA, TrebakM: The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 456: 769-785, 2008
7. Shanahan CM: Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat Rev Nephrol 9: 661-670, 2013
8. Balderman JA, Lee HY, Mahoney CE, Handy DE, White K, Annis S, Lebeche D, Hajjar RJ, Loscalzo J, Leopold JA: Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. JAmHeartAssoc 1: e003905, 2012
9. Liao XB, Zhang ZY, Yuan K, Liu Y, Feng X, Cui RR, Hu YR, Yuan ZS, Gu L, Li SJ, Mao DA, Lu Q, Zhou XM, de Jesus Perez VA, Yuan LQ: MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology 154: 3344-3352, 2013
10. Rangrez AY, M'Baya-Moutoula E, Metzinger-Le Meuth V, Hénaut L, Djelouat MS, Benchitrit J, Massy ZA, Metzinger L: Inorganic phosphate accelerates the migration of vascular smoothmuscle cells: Evidence for the involvement of miR-223. PLoS ONE 7: e47807, 2012
11. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004
12. Chen K, Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8: 93-103, 2007
13. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, InadaM, SatoM,Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764, 1997
14. Li Z, HassanMQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS: A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 105: 13906-13911, 2008
15. Huang J, Zhao L, Xing L, Chen D: MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28: 357-364, 2010
16. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC: miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol 179: 1594-1600, 2011
17. Itoh T, Nozawa Y, Akao Y: MicroRNA-141 and-200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. JBiol Chem284: 19272-19279, 2009
18. Li Z,HassanMQ, Jafferji M, Aqeilan RI, Garzon R,Croce CM, vanWijnen AJ, Stein JL, Stein GS, Lian JB: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 284: 15676-15684, 2009
19. Rensen SS, Doevendans PA, van Eys GJ: Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15: 100-108, 2007
20. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L: miR-143 and miR-145: Molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4: 197-205, 2011
21. Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E: Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int 64: 1653-1661, 2003
22. Román-García P, Carrillo-LópezN, Fernández-Martín JL,Naves-Díaz M, Ruiz-Torres MP, Cannata-Andía JB: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 46: 121-128, 2010
23. Du Y, Gao C, Liu Z, Wang L, Liu B, He F, Zhang T, Wang Y,Wang X, Xu M, LuoGZ, Zhu Y, XuQ,Wang X, KongW: Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Arterioscler Thromb Vasc Biol 32: 2580-2588, 2012
24. Sun Y, Byon CH, Yuan K, Chen J, Mao X, Heath JM, Javed A, Zhang K, Anderson PG, Chen Y: Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res 111: 543-552, 2012
25. Atlasi Y, Noori R, Gaspar C, Franken P, Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ, Fodde R: Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation. PLoS Genet 9: e1003424, 2013
26. MoeSM,DuanD,Doehle BP,O'Neill KD, Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63: 1003-1011, 2003
27. Tintut Y, Patel J, Parhami F, Demer LL: Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102: 2636-2642, 2000
28. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M: IL-10, IL-6, and TNFalpha: Central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 67: 1216-1233, 2005
29. Barreto FC, Barreto DV, Liabeuf S, Drüeke TB, Massy ZA: Effects of uremic toxins on vascular and bone remodeling. Semin Dial 22: 433-437, 2009
30. Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95: 560-567, 2004
31. ChenQ, LiuW, Sinha KM, Yasuda H, de Crombrugghe B: Identification and characterization of microRNAs controlled by the osteoblastspecific transcription factor Osterix. PLoS ONE 8: e58104, 2013
32. Wen P, Cao H, Fang L, Ye H, Zhou Y, Jiang L, Su W, Xu H, He W, Dai C, Yang J: miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res 322: 302-312, 2014
33. Mo MH, Chen L, Fu Y, Wang W, Fu SW: Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer 3: 432-448, 2012
34. ZhaoA, Li G, Péoc'hM, Genin C, GiganteM: SerummiR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol 94: 115-120, 2013
35. DieckmannKP, SpiekermannM, Balks T, Flor I, Löning T, Bullerdiek J, Belge G: MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107: 1754-1760, 2012
36. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS: A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A 108: 9863-9868, 2011
37. Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, XieH, ZhouHD,WuXP, Luo XH: A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 286: 12328-12339, 2011
38. Goettsch C, Hutcheson JD, Aikawa E: MicroRNA in cardiovascular calcification: Focus on targets and extracellular vesicle delivery mechanisms. Circ Res 112: 1073-1084, 2013
39. Naves-Díaz M, Carrillo-López N, Rodríguez-Rodríguez A, Braga S, Fernández-Coto T, Lopez-Novoa JM, López-Hernández F, Cannata-Andía JB: Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency. Menopause 17: 766-771, 2010
40. Cardús A, Panizo S, Parisi E, Fernandez E, Valdivielso JM: Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 22: 860-866, 2007
41. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) Method. Methods 25: 402-408, 2001
42. Gregory CA, Gunn WG, Peister A, Prockop DJ: An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329: 77-84, 2004